Lilium one (USM330)
Lilium Otsuka Co., Ltd. · Decision date Oct 16, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for Lilium one (USM330), a pulsed-echo ultrasonic imaging system, under 510(k) number K260605. The applicant is Lilium Otsuka Co., Ltd. of Sagamihara, Kanagawa, Japan, and the submission was received on 02/24/2026 with a decision date of 10/16/2026. The regulation number is 892.1560, the classification product code is IYO with subsequent product code ITX, and the review panel and medical specialty are both Radiology.
The filing is a Traditional 510(k) reviewed by a third party, and it is not a combination product; no predetermined change control plan was authorized. SESE means the device was cleared as substantially equivalent to a predicate, not approved through the PMA pathway. The source page does not identify the predicate device, describe the device's components or any changed item, or give indications for use, so those details remain unknown from this record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260605
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Lilium Otsuka Co., Ltd.
- Product code
- IYO
- Decision code
- SESE
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Imaging, Pulsed Echo, Ultrasonic.
- Applicant
- Lilium Otsuka Co., Ltd.
- Product code
- IYO
- FDA device class
- 2
FDA decision timeline
K260605 received
Application receipt date recorded by FDA.
K260605 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IYO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Evident Vascular, Inc. | 510(k) clearance | Oct 28, 2026 | FDA | |
Accuro XVK262093 | Rivanna Medical, Inc. | 510(k) clearance | Oct 20, 2026 | FDA |
MD-6000S Bladder ScannerK260313 | MEDA Co., Ltd. | 510(k) clearance | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Lilium Otsuka Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Kanagawa
Sources and methodology
- Original FDA record: K260605
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

